{"entity":{"type":"insider","cik":"0001695788","url":"/insider/0001695788","json_url":"/insider/0001695788.json","name":"Rosenberger Brian","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2022-07-20","last":"2023-09-14","span_basis":"filed_date"},"name_variants":[{"name":"Rosenberger Brian","source":"filing","n_filings":3,"first_seen":"2022-07-20","last_seen":"2023-09-14"}],"transactions":[{"id":8284336,"accession":"0001062993-23-018021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-018021","line_url":"/filing/0001062993-23-018021#line-2","is_derivative":false,"issuer_cik":"0001621443","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001621443","owner_cik":"0001695788","owner_name":"Rosenberger Brian","owner_display_name":"Rosenberger Brian","owner_url":"/insider/0001695788","role":"Officer (VP, Commercial & Business Dev)","role_mark":"O","role_mark_label":"Officer (VP, Commercial & Business Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Commercial & Business Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6411.0,"shares_display":"6,411","price_per_share":1.3257,"price_display":"1.33","price_state":"stated","total_value":8499.0627,"total_display":"8,499.06","total_whole":"8,499","shares_owned_after":249559.0,"shares_owned_after_display":"249,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-13","filed_date":"2023-09-14","scope":"insider"},{"id":8600309,"accession":"0001062993-23-001385","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-23-001385","line_url":"/filing/0001062993-23-001385#line-1","is_derivative":false,"issuer_cik":"0001621443","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001621443","owner_cik":"0001695788","owner_name":"Rosenberger Brian","owner_display_name":"Rosenberger Brian","owner_url":"/insider/0001695788","role":"Officer (VP, Commercial & Business Dev)","role_mark":"O","role_mark_label":"Officer (VP, Commercial & Business Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Commercial & Business Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12663.0,"shares_display":"12,663","price_per_share":0.5978,"price_display":"0.60","price_state":"stated","total_value":7569.9414,"total_display":"7,569.94","total_whole":"7,570","shares_owned_after":94848.0,"shares_owned_after_display":"94,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-25","scope":"insider"},{"id":6146027,"accession":"0001062993-22-016557","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-016557","line_url":"/filing/0001062993-22-016557#line-2","is_derivative":false,"issuer_cik":"0001621443","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001621443","owner_cik":"0001695788","owner_name":"Rosenberger Brian","owner_display_name":"Rosenberger Brian","owner_url":"/insider/0001695788","role":"Officer (VP, Commercial & Business Dev)","role_mark":"O","role_mark_label":"Officer (VP, Commercial & Business Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Commercial & Business Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4289.0,"shares_display":"4,289","price_per_share":1.1,"price_display":"1.10","price_state":"stated","total_value":4717.9,"total_display":"4,717.90","total_whole":"4,718","shares_owned_after":107511.0,"shares_owned_after_display":"107,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-19","filed_date":"2022-07-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001621443","name":"Zynerba Pharmaceuticals, Inc.","url":"/issuer/0001621443","role":"Officer (VP, Commercial & Business Dev)","n_filings":3,"first_seen":"2022-07-20","last_seen":"2023-09-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001695788","retrieved_at":"2026-08-27T01:48:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}